Piper Jaffray Initiates Nexvet Biopharma At Overweight
March 02, 2015 at 09:49 AM EST
Piper Jaffray initiated coverage on Nexvet Biopharma Public Limited Company (NASDAQ: NVET) with a Overweight rating, according to ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.